508 results on '"Gazzard, Gus"'
Search Results
2. Systematic Literature Reviews Comparing the Long-Term Safety Outcomes for the Port Delivery System with Ranibizumab (PDS) Versus Other Ocular Implants
3. Treatment expectations in glaucoma: what matters most to patients?
4. Clinical risk stratification in glaucoma
5. Evaluating Primary Treatment for People with Advanced Glaucoma: Five-Year Results of the Treatment of Advanced Glaucoma Study
6. Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study
7. The Impact of Baseline Intraocular Pressure on Initial Treatment Response in the LiGHT Trial: Selective Laser Trabeculoplasty versus Medication
8. Glaucoma: now and beyond
9. Impact of glaucoma medications on the ocular surface and how ocular surface disease can influence glaucoma treatment
10. Five-Year Visual Field Outcomes of the HORIZON Trial
11. List of contributors
12. Selective laser trabeculoplasty: physiology and effects of SLT
13. Selective laser trabeculoplasty (SLT) performed by optometrists—enablers and barriers to a shift in service delivery
14. Surgical innovation in ophthalmology: challenges and opportunities
15. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial: Six-Year Results of Primary Selective Laser Trabeculoplasty versus Eye Drops for the Treatment of Glaucoma and Ocular Hypertension
16. Rethinking Prophylactic Laser Peripheral Iridotomy in Primary Angle-Closure Suspects: A Review
17. Managing risk in the face of adversity: design and outcomes of rapid glaucoma assessment clinics during a pandemic recovery
18. Prevention of angle-closure glaucoma: balancing risk and benefit
19. Priorities for health outcomes in glaucoma in an ethnically diverse UK cohort: an observational study
20. Selective laser trabeculoplasty versus 0·5% timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial
21. Energy Dose-Response in Selective Laser Trabeculoplasty: A Review
22. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
23. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
24. Visual Field Outcomes from the Multicenter, Randomized Controlled Laser in Glaucoma and Ocular Hypertension Trial (LiGHT)
25. Correction to: Selective laser trabeculoplasty (SLT) performed by optometrists —enablers and barriers to a shift in service delivery
26. Efficacy of Repeat Selective Laser Trabeculoplasty in Medication-Naive Open-Angle Glaucoma and Ocular Hypertension during the LiGHT Trial
27. Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
28. Has the EAGLE landed for the use of clear lens extraction in angle-closure glaucoma? And how should primary angle-closure suspects be treated?
29. Low-Energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial
30. Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio.
31. Finding Ophthalmic Risk and Evaluating the Value of Eye exams and their predictive Reliability (FOREVER)—A cohort study in a Danish high street optician setting: Design and methodology.
32. A Proposal for the Use of a Fixed Low-Energy Selective Laser Trabeculoplasty for Open Angle Glaucoma.
33. Response to Comment on: Five-year visual field outcomes of the HORIZON trial
34. Managing primary open-angle glaucoma in the setting of suboptimal surgical outcomes in the fellow eye
35. The COVID-19 pandemic will redefine the future delivery of glaucoma care
36. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
37. Design and Conduct of Randomized Clinical Trials Evaluating Surgical Innovations in Ophthalmology: A Systematic Review
38. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
39. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial
40. Differentiating stages of functional vision loss from glaucoma using the Disc Damage Likelihood Scale and cup:disc ratio
41. Iridotomy to slow progression of visual field loss in angle-closure glaucoma
42. Validation of the RCOphth and UKEGS glaucoma risk stratification tool 'GLAUC-STRAT-fast'.
43. Surgical innovation in ophthalmology: challenges and opportunities
44. Chapter 21 - Selective laser trabeculoplasty: physiology and effects of SLT
45. Adverse Effects and Safety in Glaucoma Patients: Agreement on Clinical Trial Outcomes for Reports on Eye Drops (ASGARD)—A Delphi Consensus Statement
46. Long-term Outcomes from the HORIZON Randomized Trial for a Schlemm’s Canal Microstent in Combination Cataract and Glaucoma Surgery
47. Intraocular pressure and diurnal fluctuation of open-angle glaucoma and ocular hypertension: a baseline report from the LiGHT China trial cohort.
48. Minimally invasive trabecular meshwork surgery for open-angle glaucoma
49. Is selective laser trabeculoplasty shifting the glaucoma treatment paradigm in developing countries?
50. Missed Opportunities in Preventing Acute Angle Closure—Needlessly Blind?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.